---
type: pitch-deck
source: deal-deck
captured: 2026-01-11
original_file: Biobase Investor Deck v2.9 SHORT.pdf
---

# Biobase ‚Äî Pitch Deck

> Extracted 2026-01-11. Original in [Drive](https://drive.google.com/drive/folders/1LPlzDIdk64E_rskEn_SZfh6FSUlIiA9-).

## Slide 1: biobase
biobase
The Agentic Operating System &
Infrastructure Layer for Clinical Data

Confidential | Biobase, Inc.

## Slide 2: The Missing Infrastructure Layer: No Data Orchestration Between Healthcare & Life Sciences
The Missing Infrastructure Layer: No Data
Orchestration Between Healthcare & Life Sciences

**Healthcare Systems**
*   EHR
*   PACS
*   LIS
*   IMS
Fragmented data silos

**Life Sciences**
*   ELN
*   LIMS
*   OMICS
*   CTMS
Disconnected R&D
Databases

**Disconnected**
*   No Orchestration
*   No Unified Layer
*   No Federated Data Access

Confidential | Biobase, Inc.

## Slide 3: The Missing Infrastructure Layer: No Data Orchestration Between Healthcare & Life Sciences
The Missing Infrastructure Layer: No Data
Orchestration Between Healthcare & Life Sciences

‚úì Orchestrates data flow & AI tooling between ecosystems

**Healthcare Systems**
*   EHR
*   PACS
*   LIS
*   IMS
‚úì Connects healthcare silos

**Biobase Agentic OS & Infrastructure Layer**
*   Data Marketplace
*   Enterprise AI Tools
*   Semantic Querying
*   AI Analytics

**Life Sciences**
*   ELN
*   LIMS
*   OMICS
*   CTMS
‚úì Connects R&D systems

Confidential | Biobase, Inc.

## Slide 4: Revenue Model
Revenue Model

The Biobase Orchestration Layer Enables Three High-Margin Revenue Streams

**Agentic Operating System (SaaS)**
*   ‚Üí The operating system for connecting, harmonizing, querying, and analyzing multimodal clinical data
*   ‚Üí Healthcare + Life Sci query their own data silos + federated networks
*   $75k-$450k ARR
*   75-80% Margin

**Federated Biobanking Marketplace**
*   ‚Üí Federated ecosystem and marketplace for healthcare partners to commercialize digital & physical data assets
*   $75k-$150k avg deal
*   50% rev share margin

**AI App Marketplace**
*   ‚Üí Deploy in house AI/ agentic models as well as 3rd party AI tools enterprise wide over the Biobase infrastructure
*   $1k-$30k avg/tool/month
*   95% margin

Land Data Pilot ($30k-$120k avg) ‚Üí Expand (SaaS) ‚Üí Accelerate (Biobank + AI Marketplace)

Confidential | Biobase, Inc.

## Slide 5: Massive Market Opportunity
Massive Market Opportunity

**2025 ‚Üí 2030 Market Growth**
*   **2030:** $245B
*   **2025:** $111B

**2030 Market Detail**
*   **TAM:** $245B
    *   **Biobanking:** $160B
    *   **Direct-To-Patient Data:** $50B
    *   **Clinical Trials:** $25B
    *   **RWD/RWE:** $10B

Both Healthcare & Pharma Ecosystems are Desperate for Orchestration Infrastructure

**Sources:** Grand View Research (Biobanking, 2024), Allied Market Research (RWD/RWE, 2024), GlobalData (Clinical Trials, 2024), EvaluatePharma (Pharma R&D, 2024), MarketsandMarkets (Direct-to-Patient Data, 2023)

## Slide 6: The Biobase Advantage
The Biobase Advantage

**Patent Moat**

**Universal Data Connector**
*   90% faster integration
*   Any data format
*   14 additional patents ready to submit

**Agentic AI System for Clinical Retrieval**
*   Federated architecture
*   Data never leaves source
*   Compliance by design
*   LLM-powered discovery
*   Natural language queries

**Strategic Moat**

**Quest Diagnostics**
*   Pathology distribution rights
*   First mover advantage ‚Äì 24-month head start

**11+ Other Lab/Healthcare Partners**
*   Zero competing platforms
*   Multi-year agreements
*   Pre-MVP revenue

**Network Moat**

**Network Flywheel**
*   SaaS platform activation ‚Üí Data supplier participation ‚Üê more data buyers purchasing ‚Üê
*   Data scout program ‚Äì referral fees
*   Two-Sided Network: Every healthcare supplier increases value for every pharma buyer, and vice versa
*   Non-linear growth & compounding returns

We are not a point solution. We‚Äôre the rails for clinical data.

Confidential | Biobase, Inc.

## Slide 7: Traction & Market Validation
Traction & Market Validation

*   **$185K** Revenue
*   **$750K+** in Contracting
*   **$19M** Active Pipeline

üí° 100% Word-of-Mouth ($0 Marketing Spend)

**Data Suppliers**
*   11 partnerships signed - Quest + 10 other labs & health systems
*   10+ in near-term funnel
*   Target: 20+ by Series A

**Buyer Demand**
*   7 of top 15 pharma in pilot negotiations
*   Pharma, AI model developers, diagnostics
*   Strong demand for multimodal data
*   Average deal size: $75k-$150k

Both sides of the ecosystem need solutions for enterprise data unification.
Product-market fit is proven. Funding will accelerate growth.

Confidential | Biobase, Inc.

## Slide 8: Deep Healthcare, AI & Data Commercialization Expertise
Deep Healthcare, AI & Data Commercialization
Expertise

*   **Todd Parker, MBA**
    Co-Founder & CEO
    danaher. Paige pictorlabs
*   **Terence O'Keeffe**
    Co-Founder & COO
    pwc Walgreens elephas
*   **Jonathan Maddison**
    Co-Founder & CTO
    OTTO Paige Grasshopper
*   **Sam Seymour, MS**
    Co-Founder & CPO
    ARTERYS Paige TEMPUS
*   **Joel Duckworth**
    Co-Founder & CCO
    OLYMPUS PHILIPS IBEX Healthcare
*   **Salvatore Raieli, PhD**
    Head of AI
    institut Curie BIOGENERA Oncodesign services

Collective experience: 500+ healthcare/pharma deployments | $150M+ revenue generated

Confidential | Biobase, Inc.

## Slide 9: Financial Projections
Financial Projections

**Revenue (millions)**
*   **Y0:** ~$0.00M
*   **Y1:** ~$2.00M (estimated from graph)
*   **Y2:** ~$12.00M (estimated from graph)
*   **Y3:** ~$40.00M (estimated from graph)
*   **Y4:** ~$100.00M (estimated from graph)
*   **Y5:** ~$245.00M

Scaling Infrastructure, Not Services

**Series A Readiness**
*   18-24 Mo
*   $3-5M ARR

**Y3 Revenue/FTE**
*   ~$1.1M

**Y5 Target**
*   $245M

**5-Year CAGR**
*   219%

Confidential | Biobase, Inc.

## Slide 10: Use of Funds
Use of Funds

**Platform Development**
*   V1 production orchestration layer with federated querying & marketplace integration

**Team Expansion**
*   AI/Data Engineers, Regulatory/Compliance, Customer Success

**Supplier Network**
*   Expand to 20+ clinical partners with millions of multimodal data points

**Go-to-Market**
*   Marketing, sales, BD campaigns to accelerate pipeline conversion

**IP & Compliance**
*   Convert provisional patents; advance SOC 2/ISO/IRB readiness

**AI Development**
*   Semantic search, graph networks, vector embeddings, agentic workflows & tools

**Series A Milestones**
*   ‚úì 20+ Clinical Partners
*   ‚úì 10-15 Enterprise Customers
*   ‚úì $3-5M ARR Target

Confidential | Biobase, Inc.

## Slide 11: Invest in the Healthcare Data Infrastructure Layer of the Future
Invest in the Healthcare Data Infrastructure Layer
of the Future

**[Contact]**
*   Todd Parker | CEO | Email | LinkedIn
*   Terence O'Keeffe | COO | Email | LinkedIn
*   Jonathan Maddison | CTO | Email | LinkedIn
*   Sam Seymour | CPO | Email | LinkedIn

Confidential | Biobase, Inc.
